⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Pomerantz LLP Highlights Class Action Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Pomerantz LLP Highlights Class Action Filing Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Pomerantz LLP Calls Attention to Class Action Involving Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Pomerantz LLP Highlights Class Action Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?
newsfilecorp.com
GOSS
Pomerantz LLP Calls Attention to Class Action Filed Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
GOSS
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit — The Gross Law Firm
globenewswire.com
GOSS
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman
prnewswire.com
GOSS